Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 17:20:48 GMT 2023
by
admin
on
Sat Dec 16 17:20:48 GMT 2023
|
Protein Type | SINGLE-DOMAIN ANTIBODY |
Protein Sub Type | BIVALENT VHH |
Sequence Origin | CAMEL |
Sequence Type | COMPLETE |
Record UNII |
2R27AB6766
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Related Record | Type |
---|
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1327
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
||
|
FDA ORPHAN DRUG |
277909
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
||
|
WHO-ATC |
B01AX07
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9511
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
DB06081
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
100000166854
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
915810-67-2
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
Caplacizumab
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
2110604
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
ALTERNATIVE | |||
|
2R27AB6766
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
AB-28
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
SUB181150
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
Caplacizumab
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
2110605
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
CHEMBL2109624
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
m12117
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
5308
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
2R27AB6766
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY | |||
|
C128625
Created by
admin on Sat Dec 16 17:20:49 GMT 2023 , Edited by admin on Sat Dec 16 17:20:49 GMT 2023
|
PRIMARY |
From | To |
---|---|
1_22 | 1_96 |
1_153 | 1_227 |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INNOVATOR->PARENT |
|
||
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|